Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Rowan House, Aberford road, United Kingdom Clinical Trials

A listing of Rowan House, Aberford road, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (3319) clinical trials

The primary purpose of this study is to demonstrate improvements in lung function for subjects treated with UMEC/VI compared with UMEC for 24 weeks. The effect of UMC/VI, UMEC, and salmeterol with respect to patient HRQoL measured through patient reported outcomes (PROs) Questionnaires, symptoms and lung function will also be ...

Phase

Northern California research is looking for participants who have a diagnosis of gout to participate in a new study. Participants must be ages 18-85 and taking medication to control their uric acid levels. The study being conducted is for an already FDA approved medication that would be taken in combination ...

Phase

The drug being tested in this study is called Vedolizumab. Vedolizumab will be administered as an IV infusion. It is being tested in this study with new doses. This study will investigate the efficacy and safety of dose optimization of vedolizumab IV, compared with standard dosing of vedolizumab IV, over ...

Phase

This is a prospective, longitudinal, non-interventional study in an adult population (age ≥ 18 years) of men and women who have been diagnosed with select subcategories of either MF or ET. Patients will be enrolled over approximately 24 months and observed for a minimum of 36 months from enrollment.

Phase

Protocol # MNK14274069 This is a multicenter, multiple dose study to estimate the response rate, and examine the safety of, Acthar in subjects with RRMS who have not responded to high dose intravenous methylprednisolone (IVMP), oral prednisone, or oral methylprednisolone. Approximately 66 subjects will be randomized.

Phase

This is a phase 4, open-label, multicenter study to investigate the efficacy and safety of dose optimization of vedolizumab IV, compared with standard dosing of vedolizumab IV, over a 30-week treatment period. This study will enroll adult subjects with moderately to severely active ulcerative colitis (UC) who are eligible for ...

Phase

The purpose of the study is to determine whether H.P. Acthar® Gel (repository corticotropin injection) is helpful for adult patients with FSGS who still have an abnormal amount of protein in their urine, despite prior treatment.

Phase

The EXPLORE study will observe the safety and effectiveness of using the medication lesinurad in combination with a xanthine oxidase inhibitor (XOI), compared to using an XOI alone, to lower uric acid levels in the blood of adult patients with gout and kidney disease.

Phase

Eligibility Criteria: Inclusion Criteria:•Age > or equal to 18 years of age•History of non-paroxysmal form of AF as defined by the HRS/EHRA/ECAS Consensus Statement:◦Persistent AF shall be defined as continuous AF that is sustained beyond seven days. Episodes of AF in which a decision is made to electrically or pharmacologically ...

Phase